Anibal Drelichman is an Oncology physician affiliated with Providence Hospital. OpenAlex indexes 36 publications with 946 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
22301 Foster Winter Dr
2nd Floor
Southfield, MI 480753707
Telephone
248-552-0620Registry record last updated 18 Feb 2011.
Industry payments
42 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Aveo Pharmaceuticals, Inc.Program year20252 payments
- Merck Sharp & Dohme LLCProgram year20253 payments
- Apellis Pharmaceuticals, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
98.5%RANK Ligand Inhibitor98.5%Denosumab100%Part B, office-administered≥43 patientsCancer & immunology
1%Antimetabolite0.6%Hydroxyurea100%Part D<11 patientsCytochrome P450 17A1 Inhibitor0.4%Abiraterone Acetate100%Part D<11 patientsBlood & clotting
0.5%Factor Xa inhibitor0.5%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Combined hedgehog and EGFR inhibition in pancreatic cell lines treated with gemcitabine.
Journal of Clinical Oncology
2011 - Southwest Oncology Group Phase II Study of Ispinesib in Androgen-Independent Prostate Cancer Previously Treated with Taxanes
Clinical Genitourinary Cancer
2008
Similar KOLs
Other experts from the same institution or the same specialty.
Vasundhara Tolia, MBBS
Providence Hospital
Sheldon Stoffer, MD
Providence Hospital
Carolyn Gaulden, MD, MBA, MSW
Providence Hospital
Patrick Alexander, MD
Providence Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”